Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
PURITAN MEDICAL
RANDOX LABORATORIES

Autoantibody Targets Identified in Lupus Patients

By Labmedica International staff writers
Posted on 09 Dec 2013
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Image: Blood smear showing an “LE cell” from a patient with systemic lupus erythematosus (Photo courtesy of Imperial College London).
Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that can cause damage to multiple organ systems.

A microarray has been developed to identify cytokines, chemokines, and other circulating proteins as potential targets of the autoantibodies produced by SLE patients, and are implicated in inflammatory autoimmune disease and diseases of immune deficiency.

Scientists at Stanford University (CA, USA) and their colleagues from other institutes designed a nitrocellulose-surface microarray containing human cytokines, chemokines, and other circulating proteins and demonstrated that the array permitted specific detection of serum factor-binding probes. They used antibody binding assays and an indirect B cell-activating factor (BAFF) enzyme-linked immunoassay to detect autoantibodies.

Serum profiling from individuals with SLE revealed that among several targets, elevated immunoglobulin G (IgG) autoantibody reactivity to BAFF was associated with SLE compared with control samples. BAFF reactivity correlated with the severity of disease-associated features, including interferon (IFN)-α–driven SLE pathology. Of the other novel targets of autoantibodies they identified, the observed reactivity to the growth factors epidermal growth factor, (EGF), and somatotropin (HGH) were of particular interest.

Further screening of samples derived from individuals with SLE and other inflammatory autoimmune diseases revealed striking array reactivity to these and other growth factor targets, including various isoforms of fibroblast growth factor (FGF). The idea of an inverse relationship between inflammation- and growth factor-mediated pathways is an area of increasing interest in the field of inflammation.

The authors concluded that the implication of growth factor-targeted autoantibodies in the potential trade-off between tissue growth/repair and inflammation is one intriguing avenue to pursue. That serum factor-protein microarrays facilitated the detection of autoantibody reactivity to serum factors in human samples and that BAFF-reactive autoantibodies may be associated with an elevated inflammatory disease state within the spectrum of SLE. The study was published on November 25, 2013, in the Journal of Clinical Investigation.

Related Links:

Stanford University



77 ELEKTRONIKA
KARL HECHT GMBH & CO KG
CELLAVISION AB

Channels

Genetic Tests

view channel
Image: Histopathology of a coronary artery with the most common form of obstructive coronary artery disease (atherosclerosis) and marked luminal narrowing (Photo courtesy of Nephron).

Blood Test Influences Clinical Decisions in Coronary Artery Disease

Clinicians need better approaches to evaluating women at midlife and beyond who present to primary care with chest pain and related symptoms such as an individual's current likelihood of having obstructive... Read more

Microbiology

view channel
Image: The VIKIA Malaria Ag Pf/Pan rapid diagnostic test (Photo courtesy of IMACCESS).

Malaria Rapid Diagnostic Test Evaluated At Point-Of-Care

For over a decade, the development of malaria rapid diagnostic tests (RDTs) has enabled reliable biological diagnostic testing in all situations where previously only clinical diagnosis was available.... Read more

Industry News

view channel

Clinical Lab Automation Sector at USD 5.4 Billion and Growing

Lab automation systems sold to clinical laboratories reached USD 5.4 billion in sales in 2014. Shortage of personnel will further drive these purchases, as will a need for new systems, according to a new market research report on the status of lab automation in both clinical and drug-discovery lab segments.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.